Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes

NCT02497313 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Isotonic saline
DRUG: Metformin placebo
DRUG: Cholecystokinin
DRUG: Metformin

Sponsor

University Hospital, Gentofte, Copenhagen